Related Experiment Video
Updated: Aug 10, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Gentamicin removal during intermittent peritoneal dialysis
Abstract:
Gentamicin removal during intermittent peritoneal dialysis was studied in 13 uremic patients. The peak serum level after 80 mg of gentamicin intravenous drip was 6.00 +/- 1.3 micrograms/ml with a serum half-life of 13.6 +/- 4.07 h. The gentamicin dialysate level did not correlate with the corresponding serum concentration. The peritoneal gentamicin clearance (10.0 +/- 3.65 ml/min) correlated with the rate of protein loss, but not with the peritoneal clearances of urea and creatinine. When 4% glucose dialysate was used, the clearance of the drug increased considerably along with the ultrafiltration rate. Adding gentamicin (5 micrograms/ml) to the dialysate resulted in a sustained serum drug level. The mechanism of gentamicin transport through the peritoneal membrane is discussed. The study demonstrated significant removal of gentamicin during intermittent peritoneal dialysis.
Insights
Intermittent peritoneal dialysis effectively removes gentamicin in uremic patients. Dialysate drug concentration and protein loss significantly influence gentamicin clearance during this treatment.
Area of Science:
- Nephrology
- Pharmacokinetics
- Dialysis
Background:
- Gentamicin is an antibiotic commonly used for infections.
- Uremic patients often require dialysis, necessitating an understanding of drug removal during this process.
Purpose of the Study:
- To investigate the removal of gentamicin during intermittent peritoneal dialysis (IPD).
- To determine factors influencing gentamicin clearance and its pharmacokinetics in uremic patients undergoing IPD.
Main Methods:
- Studied 13 uremic patients receiving gentamicin intravenously.
- Measured serum and dialysate gentamicin levels during IPD.
- Assessed peritoneal gentamicin clearance and its correlation with protein loss and other solutes.
Main Results:
- Significant gentamicin removal was observed during IPD.
- Peritoneal gentamicin clearance correlated with protein loss and was enhanced by 4% glucose dialysate and increased ultrafiltration.
- Gentamicin dialysate levels did not correlate with serum concentrations.
Conclusions:
- Intermittent peritoneal dialysis is an effective method for gentamicin removal in uremic patients.
- Factors such as protein loss and dialysate composition influence gentamicin clearance during IPD.
Related Concept Videos
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Acute Kidney Injury V: Interprofessional Care

